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Introduction
The DIP Argo hemiprosthesis (ADIP) was designed in
2012 with the idea of replacing the destroyed / arthritic
head of the middle phalanx (P2) and was implanted in
2013 for the first time.Basically the idea was to achieve
coverage of P2 as opposed to P3 (distal phalanx),
because the last phalanx of the digit is so thin, and the
joint surface often so destroyed that the fixation of the
distal part is deemed not feasible.
The implant comprises part of thesurface of a cylinder
that covers only the articular part of the middle phalanx,
and is fixed to a stem 8mm long and very narrow,
inserted into the medullary cavity.The stem is coated
with Hydroxyapatite(HAP) and one size fits all.
Methods
A midline dorsal approach is used and the extensor ten-
don divided longitudinally as routinely done. 2mm off
the head of P2 is removed, then a midline 1.2mmK-wire
is fixed as guide in the medullary cavity.
With a special rasp it’s possible simultaneously to flat-
ten part of the head of the middle phalanx, in order to
prepare the site of the stem of the ADIP and to smoothen
the proximal surface of the distal phalanx too, since it is
often damaged.
The trial implant is then inserted, and more resection
is carried out if necessary (especially when tested in flex-
ion).The ADIP prosthesis is inserted, impacted in its
definitive position, and finally the mobility of the DIP is
tested.If necessary the volar portion of the condyle of P2
is resected as a chamfer cut.Repair of the extensor sys-
tem is performed just before skin closure.
Results
Our series is very small with a relatively short maximal
follow-up of 18 months.The most frequent indication
was painful osteoarthritis of the DIPJ. In 13 cases, pain
disappeared, while mobility increased to 30° in 9 cases,
and less than 15° in 5 patients.An extension lag (of less
than 10°) of the distal phalanx was seen in 2 instances,
which was really a lack of hyperxetension.No lateral
instability was seen.
Discussion and conclusion
The fact that the pain disappears is very interesting, and
can be explained to some extent by the possible dener-
vation caused by the dorsal approach, similar to other
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prostheses being inserted with the same approach. The
recovery time is determined by the period needed for
rehabilitation of the repaired extensor system. Mobility
is limited initially, but sufficient for grasp without pain,
which makes this the reason of the choice for patients
instead of fusion.
It is still too early to predict the ‘natural history’ of
this prosthesis, but for those on the 18 months’ follow-
up, the fixation seems very good,with good density of
the bone close to the stem, and against the implant
himself.No loosening was seen.
Caveat: In case of a bad result it is easy to perform
fusion as before.
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